Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

G. Whitney, Cynthia; M. Farley, Monica; L. Hadler, James; H. Harrison, Lee; M. Bennett, Nancy; Lynfield, Ruth; Reingold, Arthur; R. Cieslak, Paul; Pilishvili, Tamara; Jackson, Delois; R. Facklam, Richard; H. Jorgensen, James; Schuchat, Anne

doi:10.1056/nejmoa022823

Public

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Published in New England Journal of Medicine • Apr 30, 2003

Authors:

Cynthia G. Whitney

Monica M. Farley

James L. Hadler

Abstract

BACKGROUND: In early 2000, a protein-polysaccharide conjugate vaccine targeting seven pneumococcal serotypes was licensed in the United States for use in young children. METHODS: We examined population-based data from the Active Bacterial Core Surveillance of the Centers for Disease Control and Prev...

Subject

Medicine

Streptococcus pneumoniae

Pneumococcal conjugate vaccine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!